Abstral is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, and an opioid used for the management of episodes of breakthrough pain experienced by cancer patients
Overactive bladder is a condition that affects one in five Canadian women over the age of 35 and one in seven Canadian men over the age of 35,
Roche will increase the trial size from 360 to 770 participants, and a favorable outcome to the trial could be used by Roche to support a marketing application
Taiba expects to launch Kalbitor in 2012. The profits on Kalbitor sales within the licensed territory will be shared by Dyax and taiba. Dyax president and chief executive
The deal, which is based on full R&D cost sharing, includes co-development, manufacturing and commercialization of the biosimilar compounds. Dr. Reddy’s will carry out early product development and
The generic version of Actelion’s Tracleer is indicated for pulmonary arterial hypertension. Mylan Canada president and CEO Dick Guest said, "By providing access to more affordable generic drugs,
The first notice of allowance is issued for patent application claiming BL-1021’s composition. Once issued, the patent will be valid until at least September 2022. The second one
The company manufactures a recombinant mammalian cell produced third-generation Sci-B-Vac in its biologics manufacturing facility in Rehovot, Israel. The multiple clinical studies conducted on Sci-B-Vac have demonstrated that
The marketing authorization follows the recently announced approval in Austria. The approvals were based on the completion of the decentralized regulatory procedure (DCP) in the European Union, in
The 24-week, double-blind, multinational, placebo-controlled, randomized study is designed to assess the safety and efficacy of Elagolix in 875 women, age 18 to 49, suffering with moderate-to-severe endometriosis-associated
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.